You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 9, September 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Report
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunology
 •Immunologic Disorders
 •Ocular/ Adnexal Tumors
 •Alert me on articles by topic

Primary Intraocular Lymphoma With a Low Interleukin 10 to Interleukin 6 Ratio and Heterogeneous IgH Gene Rearrangement

Arch Ophthalmol. 1999;117:1239-1242.

Primary intraocular lymphoma is almost always a central nervous system B-cell non–Hodgkin lymphoma. Primary intraocular lymphoma is commonly diagnosed by demonstrating lymphoma cells in the vitreous or cerebrospinal fluid. An interleukin (IL) 10 to IL-6 ratio greater than 1.0 in these fluids and the detection of immunoglobulin gene rearrangement are useful adjuncts in the diagnosis of primary intraocular lymphoma. We report a case of primary intraocular lymphoma diagnosed by chorioretinal biopsy in which no malignant cells were identified in the vitreous and in which the IL-10 to IL-6 ratio was less than 1.0. The detection of IgH gene rearrangement heterogeneity in the tumor cells by polymerase chain reaction, a high tumor mitotic figure rate, and the rapid onset of multiple brain lesions suggest an aggressive malignant neoplasm.


Ronald R. Buggage, MD; Gisela Velez, MD, MPH; Brenda Myers-Powell, MD, PhD; DeFen Shen, PhD; Scott M. Whitcup, MD; Chi-Chao Chan, MD
From the Laboratory of Immunology and the Clinical Branch, National Eye Institute, National Institutes of Health, Bethesda, Md.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

IL-10 Measurement in Aqueous Humor for Screening Patients with Suspicion of Primary Intraocular Lymphoma
Cassoux et al.
IOVS 2007;48:3253-3259.
ABSTRACT | FULL TEXT  

Protocol for the Use of Polymerase Chain Reaction in the Detection of Intraocular Large B-Cell Lymphoma in Ocular Samples
Lobo et al.
J. Mol. Diagn. 2007;9:113-121.
ABSTRACT | FULL TEXT  

High-Dose Methotrexate for Intraocular Lymphoma
Batchelor et al.
Clin. Cancer Res. 2003;9:711-715.
ABSTRACT | FULL TEXT  

Validation of a Diagnostic Multiplex Polymerase Chain Reaction Assay for Infectious Posterior Uveitis
Dabil et al.
Arch Ophthalmol 2001;119:1315-1322.
ABSTRACT | FULL TEXT  

Primary Intraocular Lymphoma With a Low Interleukin 10 to Interleukin 6 Ratio and Heterogeneous IgH Gene Arrangement
Akpek et al.
Arch Ophthalmol 2000;118:731-732.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.